SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery

Core Insights - SciSparc Ltd. has initiated a new program to advance 3D protein modeling using quantum computing technology, aiming to enhance drug discovery accuracy and potentially lead to breakthroughs in structural biology and personalized medicine [1][3] Company Overview - SciSparc Ltd. is a clinical-stage pharmaceutical company focused on developing therapies for central nervous system disorders, with a portfolio that includes cannabinoid pharmaceuticals [4] Initiative Details - The new Initiative will leverage quantum computing to improve the accuracy of predicting protein structures and their interactions with ligands, addressing the limitations of traditional computing methods [3][6] - A dedicated research team will be formed to integrate quantum computing algorithms into 3D protein modeling, with initial efforts focusing on refining these algorithms for drug discovery applications in neurological and rare diseases [3][6] Collaboration and Development - The company plans to collaborate with leading experts in quantum computing and structural biology to build its capabilities in this area [3] - A new wholly owned Israeli subsidiary will be established to operate the Initiative, further enhancing the company's research and development efforts [3]